Both BRCA1-wild type and mutant triple-negative breast cancers show - ecancer
ecancer,
Oncotarget features "MLN4924 treatment induces DNA damage by stabilising CDT1 and accumulates the cells in S phase which are…
Oncotarget features "MLN4924 treatment induces DNA damage by stabilising CDT1 and accumulates the cells in S phase which are…
Oncotarget Volume 11 Issue 8 features Figure 8, "MLN4924 treatment induces DNA damage by stabilizing CDT1 and accumulates the…